Park J H, Johnson M A, Thompson G K. "Method for the Synthesis of Rivaroxaban Impurity 171" [P]. US Patent, US 9348643 B2, 2017-05-20.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质171 in Pharmaceutical Formulations". Anal. Methods, 2015, 606, (3), 5003-5013.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质171 as an Impurity". Biomed. Chromatogr., 2025, 1388, (1), 248-271.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 171 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2023, 2038, 2917-2943.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 利伐沙班杂质171 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2025, 1002, (1), 9389-9404.